Integumen Plc Reports A 540% Surge In Revenues For H1 FY19

Integumen Plc (AIM: SKIN), for the six months ended 30 June 2019 has reported a huge surge of 540 per cent in revenues from continuing operations to £346,697 from £54,149 in H1 2018. Company’s EBITDA loss from continuing operations reduced by 32 per cent to £370,102 from £544,278 of H1 2018. During the reported period, the company signed an agreement with 4 Blue-Chip (US and EU) clients for test services on household name soap and cosmetic brands.

On 11th September 2019, at the time of writing, GMT 08:02 AM, SKIN shares were trading at GBX 1.72, down by 0.20 points or 10.68% against the previous day closing price.